Supernus Pharmaceuticals
SUPN
#4301
Rank
S$2.68 B
Marketcap
$48.62
Share price
0.55%
Change (1 day)
34.07%
Change (1 year)

Earnings for Supernus Pharmaceuticals (SUPN)

Earnings in 2024 (TTM): S$50.82 Million

According to Supernus Pharmaceuticals 's latest financial reports the company's current earnings are S$0.63 Billion. In 2023 the company made an earning of S$6.88 Million a decrease over its 2022 earnings that were of S$90.09 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Supernus Pharmaceuticals from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) S$50.82 M637.96%
2023 S$6.88 M-92.36%
2022 S$90.09 M-29.8%
2021 S$0.12 B-49.79%
2020 S$0.25 B12.99%
2019 S$0.22 B7.58%
2018 S$0.21 B54.9%
2017 S$0.13 B84.25%
2016 S$73.67 M202.27%
2015 S$24.37 M-462.04%
2014 -S$6.74 Million-94%
2013 -S$0.12 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$0.29 Billion-666.56%๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.97 B 3,876.06%๐Ÿ‡บ๐Ÿ‡ธ USA
S$13.48 B 27,022.97%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$9.15 Billion-18,483.92%๐Ÿ‡บ๐Ÿ‡ธ USA
S$9.00 B 18,011.37%๐Ÿ‡บ๐Ÿ‡ธ USA
S$24.43 B 49,052.95%๐Ÿ‡บ๐Ÿ‡ธ USA